Processa Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PCSA
Share price (8/12/26): $2.56
Market cap (8/12/26): $8.516 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 99 pages Continued

from S-1/A 36 pages Acquisition Agreement by and Among Heatwurx, Inc., a Delaware Corporation Processa Therapeutics, LLC a Delaware Limited Liability Company and Promet Therapeutics, LLC a Delaware Limited Liability Company Dated as of October 2, 2017 1

from 8-K 36 pages Acquisition Agreement by and Among Heatwurx, Inc., a Delaware Corporation Processa Therapeutics, LLC a Delaware Limited Liability Company and Promet Therapeutics, LLC a Delaware Limited Liability Company Dated as of October 2, 2017 1

from S-1 18 pages Asset Purchase Agreement